Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease

Atherosclerosis

Volumn 162, Issue 1, 2002, Pages 157-162

  Stanger, Olaf H ^a   Semmelrock, Hans J ^a   Rehak, Peter ^a   Tiran, Beate ^a   Meinitzer, Andreas ^a   Rigler, Bruno ^a   Tiran, Andreas ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Antibodies; Chlamydia pneumoniae; Coronary artery disease; Homocysteine; Risk factors

Indexed keywords

ANTILIPEMIC AGENT; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; FOLIC ACID; HOMOCYSTEINE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE;

ADULT; ANTIBODIES, BACTERIAL; AUSTRIA; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MULTICENTER STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SMOKING;

EID: 0036226468     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00686-4     Document Type: Article

References (42)

1. Serum total homocysteine and coronary heart disease
2. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
3. Plasma homocyst(e)ine levels in men with premature coronary artery disease
4. Plasma homocysteine levels and mortality in patients with coronary artery disease
5. Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
6. Homocysteine modulates the expression of a specific cytokine (monocyte chemoattractant protein 1) in human aortic endothelial cells
7. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
8. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
9. Chronic infections and coronary heart disease: Is there a link?
10. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary disease
11. Chlamydia pneumoniae - Specific circulating immune complexes in patients with chronic coronary heart disease
12. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
13. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissue
14. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
15. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
16. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
17. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response
18. The pathogenesis of atherosclerosis: A perspective for the 1990s
19. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
20. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
21. High-performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum
22. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen
23. 6 in human plasma with graphitic carbon column
24. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
25. Epidemiology of Chlamydia pneumoniae infection in a randomly selected population in a developed country
26. Chlamydia pneumoniae, strain TWAR and atherosclerosis
27. Chlamydia pneumoniae (TWAR)
28. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
29. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease
30. Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart disease
31. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association
32. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies
33. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease-negative results of a case-control study
34. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by microimmunofluorescence and ELISA
35. Serological tests for Chlamydia pneumoniae
36. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease
37. Folic acid and neutrophil dysfunction
38. Serum folate in viral and mycoplasmal infections
39. Folate deficiency and cervical dysplasia
40. Acquisition and synthesis of folates by obligate intracellular bacteria of the genus Chlamydia
41. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis
42. Serum homocysteine increases after therapy with fenofibrate or bezafibrate